This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.

Released: July 12, 2026·Last reviewed: October 15, 2026·Prices re-read October 15, 2026 (rows marked)·Methodology v4.1

Researched By

Medical Researcher · Western University of Health Sciences

Medically Reviewed By

Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: October 15, 2026 · This page is informational and does not constitute medical advice.

This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.

MEDVi review (2026): pricing, programs, pros & limitations

Verdict

Compounded and brand-name options across 49 states. On October 15, 2026 its main page showed unfilled price placeholders and an advertising page printed two different prices, so we list no MEDVi price. This review reflects figures marked reported — pending verification as of July 12, 2026; where a figure is provider-reported we say so rather than presenting it as independently confirmed.

What does this provider actually offer?

MEDVi snapshot — verification status per field, July 12, 2026
Field	Detail	Status
Starting price	Not used: its pages print conflicting prices (Oct 15)	Promotional
Renewal price	Not printed consistently on Oct 15	Reported — pending verification
Highest-dose price	Not stated on Oct 15	Reported — pending verification
Membership fee	$0	Reported — pending verification
Labs	Pending research	Reported — pending verification
Shipping	Included	Reported — pending verification
Commitment	Monthly	Reported — pending verification
Pharmacy	Not independently verified	Reported — pending verification
Clinician	Physician included	Reported — pending verification
States served	49 states	Reported — pending verification

What does it actually cost at a maintenance dose?

Compounded and brand-name options across 49 states. Refill rates are $299 for semaglutide and $399 for tirzepatide.

Limitation: The $179 headline is a FIRST-MONTH rate only — refills are $299. Tirzepatide reaches $499/month at the 10, 12.5 and 15mg doses.

Who prescribes it, and what does the clinical review involve?

A legitimate GLP-1 program requires a licensed clinician to review the patient's history before any prescription. Physician included. Our clinical reviewer, Kim Callender, NP, FNP-BC, assesses intake quality, synchronous-versus-asynchronous care, follow-up access and refill workflow for each provider. Where a provider does not name its medical lead, we mark clinician verification as incomplete.

Which pharmacy fills it, and where does the medication come from?

Pharmacy transparency is one of the strongest legitimacy signals. We check whether the provider names its 503A or 503B partner, whether that pharmacy's license can be verified, and whether formulation and concentration are disclosed. For MEDVi: Not independently verified.

Compounding status — read before enrollingCompounded drugs are not FDA-approved: the agency does not review them for safety, effectiveness or quality before they are marketed. Federal law also bars compounding drugs that are essentially a copy of a commercially available approved product — a bar that is lifted only while the drug is on the FDA shortage list. Both shortages are over. The FDA declared the tirzepatide shortage resolved on October 2, 2024 and the semaglutide shortage resolved on February 21, 2025, and enforcement discretion ended for all compounders between February 18 and May 22, 2025. On April 30, 2026 the FDA went further, proposing to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list on a finding of no clinical need. Routine compounding of these molecules is therefore no longer lawful on the basis that made the market — a fact most comparison sites still describe as "permanent legitimacy." It is not. The comment period on the 503B proposal closed July 30, 2026, and no final decision had been published as of October 15, 2026. On September 18, 2026 FDA told Empower Pharmacy that compounded tirzepatide and semaglutide products it examined “appear to be essentially copies” of approved drugs (warning letter 738238).

Where does it hold up, and where does it fall short?

Advantages

MEDVi: Compounded and brand-name options across 49 states. Refill rates are $299…
Pricing structure is disclosed clearly enough to evaluate
Clinician oversight is stated

Limitations

The $179 headline is a FIRST-MONTH rate only — refills are $299. Tirzepatide reaches $499/month at the 10, 12.5 and 15mg doses.
Pharmacy partner not independently verified by us yet

What did we verify, and what could we not?

Every material claim on this page traces to a source, a capture date and a verification status.

Evidence ledger — claim, source, date checked, status
Claim	Source	Checked	Status
Starting price	Provider plan documentation	July 12, 2026	Reported — pending verification
Pharmacy partner	Provider disclosure	July 12, 2026	Reported — pending verification
Clinician / medical lead	Provider disclosure	July 12, 2026	Reported — pending verification
Shipping terms	Provider terms page	July 12, 2026	Reported — pending verification
State availability	Provider disclosure	July 12, 2026	Evaluation in progress

What else should you compare it against?

Compare MEDVi against NexLife · Found · Oak Longevity. For the full field, see best GLP-1 programs and most affordable compounded tirzepatide.

What did the provider say when we asked?

MEDVi may submit factual corrections through our corrections process. Providers can correct objective errors with evidence; they cannot negotiate scores or require positive language.

Frequently asked questions

Is MEDVi legitimate?

Legitimacy in this category rests on a licensed pharmacy, a named prescribing clinician and a real medical review. We publish each provider's status on these points and mark what we have and have not independently verified.

How much does MEDVi cost?

Not used: its pages print conflicting prices (Oct 15) to start (reported — pending verification). See the pricing section for renewal and highest-dose figures.

Does MEDVi require a prescription?

Yes. Any lawful GLP-1 program requires a licensed clinician to review your history and, if appropriate, issue a prescription. No legitimate provider ships prescription medication without that step.

Sources

Provider website, terms, pricing and pharmacy-disclosure pages (captured July 12, 2026).
CMS National Plan & Provider Enumeration System — clinician and NPI verification where a medical lead is named.
U.S. Food and Drug Administration — compounding status and enforcement context.
Our published scoring methodology, version 4.1.

Spotted an error? Submit a correction.

How the dates on this page work. Manufacturer self-pay prices were re-read on 15 October 2026: NovoCare’s Wegovy page and Lilly’s Zepbound savings page. Foundayo prices are carried from LillyDirect pages archived 25 September 2026, because lilly.com blocked automated reads. Figures captured from telehealth provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row or a dated notice says so. We do not restamp a figure we have not re-read.